Research Article
Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma
Figure 1
Characterization of DDS NPs: (a) morphology, size, and zeta potential of DOX NPs; (b) morphology, size, and zeta potential of ABT-199 micelles; (c) morphology, size, and zeta potential of DDS NPs; (d) in vitro DOX releasing of free DOX, DDS NPs, and DDS NPs with HAase; (e) in vitro long-term stability of ABT-199 micelles and DDS NPs; (f) in vitro temperature stability of ABT-199 micelles and DDS NPs. The data reported are the for triplicate samples.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |